VITAL THERAPIES INC's ticker is VTL and the CUSIP is 92847R104. A total of 59 filers reported holding VITAL THERAPIES INC in Q4 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $0 | – | 860 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 860 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 860 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $6,000 | 0.0% | 860 | 0.0% | 0.00% | -57.1% |
| Q1 2018 | $6,000 | +20.0% | 860 | 0.0% | 0.01% | +133.3% |
| Q4 2017 | $5,000 | +25.0% | 860 | 0.0% | 0.00% | +50.0% |
| Q3 2017 | $4,000 | +100.0% | 860 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $2,000 | -33.3% | 860 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $3,000 | -25.0% | 860 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $4,000 | -20.0% | 860 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $5,000 | 0.0% | 860 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $5,000 | -37.5% | 860 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $8,000 | +166.7% | 860 | 0.0% | 0.01% | +500.0% |
| Q3 2015 | $3,000 | -83.3% | 860 | 0.0% | 0.00% | -88.9% |
| Q2 2015 | $18,000 | -18.2% | 860 | 0.0% | 0.01% | -18.2% |
| Q1 2015 | $22,000 | +22.2% | 860 | 0.0% | 0.01% | +10.0% |
| Q4 2014 | $18,000 | – | 860 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Truvvo Partners LLC | 575,405 | $3,913,000 | 1.45% |
| Granahan Investment Management | 556,212 | $3,782,000 | 0.27% |
| Chicago Capital, LLC | 99,500 | $677,000 | 0.09% |
| Artal Group S.A. | 1,000,000 | $6,800,000 | 0.08% |
| Tibra Equities Europe Ltd | 61,231 | $416,000 | 0.07% |
| VICTORY CAPITAL MANAGEMENT INC | 2,985,536 | $20,302,000 | 0.04% |
| Annex Advisory Services, LLC | 28,000 | $190,000 | 0.04% |
| Monashee Investment Management LLC | 14,085 | $96,000 | 0.03% |
| BALASA DINVERNO & FOLTZ LLC | 25,625 | $174,000 | 0.03% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 11,885 | $81,000 | 0.02% |